ALL (n = 36) | AML (n = 40) | All acute leukemia patients (n = 76) | |||||
---|---|---|---|---|---|---|---|
Variable | ADAM6 | PRSS1 | ADAM6 | PRSS1 | ADAM6 | PRSS1 | |
Age | Rho | −0.233 | −0.146 | 0.055 | −0.384* | −0.054 | −0.292* |
p-Value | 0.172 | 0.395 | 0.734 | 0.014 | 0.640 | 0.011 | |
N | 36 | 36 | 40 | 40 | 76 | 76 | |
TLC | Rho | −0.324 | 0.211 | 0.382* | 0.105 | 0.139 | 0.182 |
p-Value | 0.054 | 0.216 | 0.015 | 0.519 | 0.232 | 0.115 | |
N | 36 | 36 | 40 | 40 | 76 | 76 | |
Hemoglobin | Rho | 0.152 | −0.257 | 0.131 | −0.043 | 0.157 | −0.137 |
p-Value | 0.375 | 0.130 | 0.419 | 0.793 | 0.176 | 0.239 | |
N | 36 | 36 | 40 | 40 | 76 | 76 | |
Platelets | Rho | 0.132 | −0.370* | −0.113 | −0.299 | −0.045 | −0.353** |
p-Value | 0.441 | 0.026 | 0.487 | 0.061 | 0.702 | 0.002 | |
N | 36 | 36 | 40 | 40 | 76 | 76 | |
LDH | Rho | −0.618* | −0.258 | - | - | −0.618* | −0.258 |
p-Value | 0.018 | 0.374 | - | - | 0.018 | 0.374 | |
N | 14 | 14 | - | - | 14 | 14 | |
ESR | Rho | 0.491 | 0.465 | - | - | 0.491 | 0.465 |
p-Value | 0.074 | 0.094 | - | - | 0.074 | 0.094 | |
N | 14 | 14 | - | - | 14 | 14 | |
CRP | Rho | −0.269 | 0.000 | - | - | −0.269 | 0.000 |
p-Value | 0.353 | 1.000 | - | - | 0.353 | 1.000 | |
N | 14 | 14 | - | - | 14 | 14 | |
Uric acid | Rho | −0.125 | 0.180 | - | - | −0.125 | 0.180 |
p-Value | 0.671 | 0.538 | - | - | 0.671 | 0.538 | |
N | 14 | 14 | - | - | 14 | 14 | |
Blasts in BM aspirate | Rho | 0.179 | −0.009 | - | - | 0.179 | −0.009 |
p-Value | 0.296 | 0.960 | - | - | 0.296 | 0.960 | |
N | 36 | 36 | - | - | 36 | 36 | |
Blasts in BM aspirate after induction chemotherapy | Rho | - | - | 0.634** | 0.254 | 0.634** | 0.254 |
p-Value | - | - | 0.006 | 0.325 | 0.006 | 0.325 | |
N | - | - | 17 | 17 | 17 | 17 | |
Blasts in BM aspirate after 6 months | Rho | - | - | −0.167 | −0.058 | −0.167 | −0.058 |
p-Value | - | - | 0.604 | 0.857 | 0.604 | 0.857 | |
N | - | - | 12 | 12 | 12 | 12 | |
MRD after induction chemotherapy | Rho | - | - | 0.341 | 0.082 | 0.341 | 0.082 |
p-Value | - | - | 0.181 | 0.756 | 0.181 | 0.756 | |
N | - | - | 17 | 17 | 17 | 17 | |
MRD after 6 months | Rho | - | - | −0.142 | −0.204 | −0.142 | −0.204 |
p-Value | - | - | 0.696 | 0.571 | 0.696 | 0.571 | |
N | - | - | 10 | 10 | 10 | 10 | |
ADAM6 | Rho | - | −0.211 | - | 0.225 | - | 0.066 |
p-Value | - | 0.218 | - | 0.163 | - | 0.574 | |
N | - | 36 | - | 40 | - | 76 | |
PRSS1 | Rho | −0.211 | - | 0.225 | - | 0.066 | - |
p-Value | 0.218 | - | 0.163 | - | 0.574 | - | |
N | 36 | - | 40 | - | 76 | - |